These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9161657

  • 1. Cost-effectiveness of thrombolytic therapy for acute myocardial infarction.
    Castillo PA, Palmer CS, Halpern MT, Hatziandreu EJ, Gersh BJ.
    Ann Pharmacother; 1997 May; 31(5):596-603. PubMed ID: 9161657
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.
    Kent DM, Vijan S, Hayward RA, Griffith JL, Beshansky JR, Selker HP.
    J Clin Epidemiol; 2004 Aug; 57(8):843-52. PubMed ID: 15485737
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The cost-effectiveness of thrombolytic therapy following acute myocardial infarction.
    Fenn P, Gray AM, McGuire A.
    Br J Clin Pract; 1991 Aug; 45(3):181-4. PubMed ID: 1805915
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Health and cost consequences of early versus late invasive strategy after thrombolysis for acute myocardial infarction.
    Bøhmer E, Kristiansen IS, Arnesen H, Halvorsen S.
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):717-23. PubMed ID: 21450598
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparison of the cost effectiveness of treatment of acute myocardial infarct with primary angioplasty and thrombolysis ].
    Golán L, Simek S, Linhart A, Cahlík T, Palecek T, Lubanda JC, Korínek J, Beran S, Aschermann M.
    Vnitr Lek; 2003 Feb; 49(2):97-102. PubMed ID: 12728575
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of captopril therapy after myocardial infarction.
    Tsevat J, Duke D, Goldman L, Pfeffer MA, Lamas GA, Soukup JR, Kuntz KM, Lee TH.
    J Am Coll Cardiol; 1995 Oct; 26(4):914-9. PubMed ID: 7560617
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke.
    Ehlers L, Andersen G, Clausen LB, Bech M, Kjølby M.
    Stroke; 2007 Jan; 38(1):85-9. PubMed ID: 17122430
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of primary percutaneous coronary intervention versus thrombolytic therapy for acute myocardial infarction.
    Selmer R, Halvorsen S, Myhre KI, Wisløff TF, Kristiansen IS.
    Scand Cardiovasc J; 2005 Oct; 39(5):276-85. PubMed ID: 16269397
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The cost-effectiveness of thrombolysis administered by paramedics.
    Scuffham PA, Tippett V.
    Curr Med Res Opin; 2008 Jul; 24(7):2045-58. PubMed ID: 18544187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.